755 related articles for article (PubMed ID: 11190037)
1. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL
Trans Am Ophthalmol Soc; 2000; 98():471-92. PubMed ID: 11190037
[TBL] [Abstract][Full Text] [Related]
2. Conjunctival melanoma: risk factors for recurrence, exenteration, metastasis, and death in 150 consecutive patients.
Shields CL; Shields JA; Gündüz K; Cater J; Mercado GV; Gross N; Lally B
Arch Ophthalmol; 2000 Nov; 118(11):1497-507. PubMed ID: 11074806
[TBL] [Abstract][Full Text] [Related]
3. Conjunctival melanoma in the Netherlands: a nationwide study.
Missotten GS; Keijser S; De Keizer RJ; De Wolff-Rouendaal D
Invest Ophthalmol Vis Sci; 2005 Jan; 46(1):75-82. PubMed ID: 15623757
[TBL] [Abstract][Full Text] [Related]
4. Conjunctival melanoma: the role of conservative surgery and radiotherapy in regional metastatic disease.
Tatla T; Hungerford J; Plowman N; Ghufoor K; Keene M
Laryngoscope; 2005 May; 115(5):817-22. PubMed ID: 15867646
[TBL] [Abstract][Full Text] [Related]
5. Metastatic pattern and survival in disseminated conjunctival melanoma: implications for sentinel lymph node biopsy.
Tuomaala S; Kivelä T
Ophthalmology; 2004 Apr; 111(4):816-21. PubMed ID: 15051218
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of tumor-associated lymphangiogenesis in malignant melanomas of the conjunctiva.
Heindl LM; Hofmann-Rummelt C; Adler W; Bosch JJ; Holbach LM; Naumann GO; Kruse FE; Cursiefen C
Ophthalmology; 2011 Dec; 118(12):2351-60. PubMed ID: 21835473
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy for sebaceous cell carcinoma and melanoma of the ocular adnexa.
Ho VH; Ross MI; Prieto VG; Khaleeq A; Kim S; Esmaeli B
Arch Otolaryngol Head Neck Surg; 2007 Aug; 133(8):820-6. PubMed ID: 17709624
[TBL] [Abstract][Full Text] [Related]
8. Malignant conjunctival tumors invading the orbit.
Gökmen Soysal H; Ardiç F
Ophthalmologica; 2008; 222(5):338-43. PubMed ID: 18635931
[TBL] [Abstract][Full Text] [Related]
9. Conjunctival melanoma: outcomes based on tumor origin in 382 consecutive cases.
Shields CL; Markowitz JS; Belinsky I; Schwartzstein H; George NS; Lally SE; Mashayekhi A; Shields JA
Ophthalmology; 2011 Feb; 118(2):389-95.e1-2. PubMed ID: 20723990
[TBL] [Abstract][Full Text] [Related]
10. Local recurrence of soft tissue sarcoma. A Scandinavian Sarcoma Group Project.
Trovik CS;
Acta Orthop Scand Suppl; 2001 Feb; 72(300):1-31. PubMed ID: 11381580
[TBL] [Abstract][Full Text] [Related]
11. Iodine brachytherapy as an alternative to enucleation for large uveal melanomas.
Puusaari I; Heikkonen J; Summanen P; Tarkkanen A; Kivelä T
Ophthalmology; 2003 Nov; 110(11):2223-34. PubMed ID: 14597534
[TBL] [Abstract][Full Text] [Related]
12. [Management of corneo-conjunctival malignant melanoma with "no touch technique" surgical excision and corneoscleral lamellar keratoplasty].
Chen JQ; Sun MX; Sha XY; Zhang P; Lin YS; Li H; Liu YM; Chen LS
Zhonghua Yan Ke Za Zhi; 2006 Jan; 42(1):22-6. PubMed ID: 16638276
[TBL] [Abstract][Full Text] [Related]
13. [Prognostic factors in malignant melanoma of the conjunctiva. An anatomo-clinical study of 56 patients].
Desjardins L; Poncet P; Levy C; Schlienger P; Asselain B; Validire P
J Fr Ophtalmol; 1999 Apr; 22(3):315-21. PubMed ID: 10337587
[TBL] [Abstract][Full Text] [Related]
14. Mortality after uveal and conjunctival melanoma: which tumour is more deadly?
Kujala E; Tuomaala S; Eskelin S; Kivelä T
Acta Ophthalmol; 2009 Mar; 87(2):149-53. PubMed ID: 18937804
[TBL] [Abstract][Full Text] [Related]
15. Patterns of recurrence in patients with melanoma after radical lymph node dissection.
Nathansohn N; Schachter J; Gutman H
Arch Surg; 2005 Dec; 140(12):1172-7. PubMed ID: 16365238
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.
Isager P; Ehlers N; Overgaard J
Acta Ophthalmol Scand; 2004 Oct; 82(5):517-25. PubMed ID: 15453846
[TBL] [Abstract][Full Text] [Related]
17. Clinical features predictive of orbital exenteration for conjunctival melanoma.
Shields JA; Shields CL; Gündüz K; Cater J
Ophthalmic Plast Reconstr Surg; 2000 May; 16(3):173-8. PubMed ID: 10826757
[TBL] [Abstract][Full Text] [Related]
18. Selecting breast cancer patients with T1-T2 tumors and one to three positive axillary nodes at high postmastectomy locoregional recurrence risk for adjuvant radiotherapy.
Truong PT; Olivotto IA; Kader HA; Panades M; Speers CH; Berthelet E
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1337-47. PubMed ID: 15817335
[TBL] [Abstract][Full Text] [Related]
19. Factors predicting the risk of in-transit recurrence after sentinel lymphonodectomy in patients with cutaneous malignant melanoma.
Kretschmer L; Beckmann I; Thoms KM; Mitteldorf C; Bertsch HP; Neumann C
Ann Surg Oncol; 2006 Aug; 13(8):1105-12. PubMed ID: 16865591
[TBL] [Abstract][Full Text] [Related]
20. [Surgical management of orbital malignant melanoma: our experience and a report of three cases].
Poli T; Mora P; Reichegger V; Ricci R; Corradi D; Gandolfi SA; Sesenna E
Klin Monbl Augenheilkd; 2007 Oct; 224(10):794-8. PubMed ID: 17952825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
